Benzyltriazolone compounds as nonnucleoside reverse transcriptase inhibitors

Details for Australian Patent Application No. 2005266530 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Elworthy, Todd Richard; Stefanidis, Dimitrios; Dunn, James Patrick; Sweeney, Zachary Kevin

Agent Spruson & Ferguson

Pub. Number AU-B-2005266530

PCT Pub. Number WO2006/010545

Priority 60/591,311 27.07.04 US

Filing date 20 July 2005

Wipo publication date 2 February 2006

Acceptance publication date 12 April 2012

International Classifications

C07D 249/12 (2006.01) Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms

A61K 31/4196 (2006.01) - 1,2,4-Triazoles

A61P 31/18 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

22 February 2007 PCT application entered the National Phase

  PCT publication WO2006/010545 Priority application(s): WO2006/010545

12 April 2012 Application Accepted

  Published as AU-B-2005266530

9 August 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005266531-Aryl-pyridine derivatives as 11-beta-HSD1 inhibitors

2005266529-1, 1a, 5, 5a-tetrahydro-3-thia-cyclopropa'a! pentalenes: tricyclic thiophene derivatives as S1P1/EDG1 receptor agonists